NutriBand (NTRB) Assets Average (2016 - 2026)
NutriBand (NTRB) posted Assets Average of $7.2 million for Q2 2026, down 9.56% sequentially from $8.0 million in Q1 2026, and up 6.01% YoY from $6.8 million in Q2 2025.
NutriBand (NTRB) Assets Average (2016 - 2026) Analysis & Trends
NutriBand has reported Assets Average for 11 years, with the latest figure at $7.2 million in Q2 2026.
- Quarterly Assets Average rose 6.01% year-over-year to $7.2 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $7.2 million (up 6.01% YoY) and the FY2026 annual result came in at $7.5 million, changed 0.21% from the prior year.
- Assets Average fell to $7.2 million in Q2 2026 per NTRB's latest filing, from $8.0 million in the prior quarter.
- Over five years, Assets Average peaked at $14.4 million in Q3 2024 and troughed at $6.8 million in Q2 2025.
- A 5-year average of $10.2 million and a median of $9.7 million in 2025 frame the typical range for Assets Average.
- The sharpest annual moves came in 2024 and 2025: Assets Average jumped 55.21% in 2024, then plunged 43.28% in 2025.
- Over 5 years, Assets Average stood at $11.0 million in 2022, then slipped by 16.6% to $9.2 million in 2023, then surged by 42.3% to $13.1 million in 2024, then dropped by 28.96% to $9.3 million in 2025, then fell by 22.35% to $7.2 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $7.2 million, $8.0 million, and $9.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | NutriBand | 46.38 Mn | 42.37 Mn | 196,801.00 | 7.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 7.22 Mn |
| Jan 31, 2026 | 7.98 Mn |
| Oct 31, 2025 | 9.30 Mn |
| Jul 31, 2025 | 8.16 Mn |
| Apr 30, 2025 | 6.81 Mn |
| Jan 31, 2025 | 10.01 Mn |
| Oct 31, 2024 | 13.09 Mn |
| Jul 31, 2024 | 14.39 Mn |
| Apr 30, 2024 | 11.34 Mn |
| Jan 31, 2024 | 8.02 Mn |
| Oct 31, 2023 | 9.20 Mn |
| Jul 31, 2023 | 9.27 Mn |
| Apr 30, 2023 | 9.07 Mn |
| Jan 31, 2023 | 10.06 Mn |
| Oct 31, 2022 | 11.03 Mn |
| Jul 31, 2022 | 11.69 Mn |
| Apr 30, 2022 | 12.36 Mn |
| Jan 31, 2022 | 14.08 Mn |
| Oct 31, 2021 | 12.80 Mn |
| Jul 31, 2021 | 10.36 Mn |